Financials
- Market Capitalization 1.81 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.15
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2057 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.10 USD | -1.50% | -22.07% | -11.31% | -4.52% | 1.83 B USD | ||
| 2059 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.31 USD | -3.62% | -13.54% | +9.77% | -5.41% | 1.83 B USD | ||
| 2075 | ZYME Zymeworks Inc. - Common Stock | 24.67 USD | +0.04% | -5.59% | +5.88% | +39.06% | 1.80 B USD | ||
| 2088 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | +0.30% | -9.70% | +2.45% | -36.67% | 1.78 B USD |